Investors in Spain

"Aventures is an investment DAO comprised of OG Avalanche community members whose goal is to support the ecosystem. Our team boasts multiple successful dApp developers and project owners, content creators, advisors and domain experts that have come together to channel our expertise to support the Avalanche ecosystem. AVentures DAO: * Provides advisory and marketing support to new Avalanche projects * Supports Avalanche projects by investing in seed/private rounds * Incubates new projects via mentoring * Publishes technical analysis on DeFi projects"

"Additio Investment Group is a global Syndicate of Healthcare & Life Sciences Investors that support high-integrity entrepreneurs with the potential to build great businesses. We pay particular attention to EU based opportunities that are in line with our health/care industry expertise and where we can add direct value, mainly: MedTech, and Digital Health/HealthTech with a particular clinical relevance. Average ticket size of €300-500K. AiG1 (fund 1) has been successfully allocated with a high profile portfolio of 5 companies. Our Partners are committed to hands-on value creation to our Portfolio through capital allocation, expertise and access to a valuable international Network."

Pascual's Corporate Venturing arm drives innovation within the agri-food industry by tackling both global and local challenges, fostering an ecosystem that promotes value creation and advancement. They specialize in venture building, launching startups with disruptive innovations that align with Pascual's strategic vision. Additionally, Pascual's venture capital initiatives invest in promising startups to integrate new technologies and explore strategic opportunities. Through open innovation, they collaborate strategically with startups to address specific challenges faced by Pascual. Their Mylkcubator program accelerates startups, providing comprehensive support across strategy, people operations, governance, operations, network building, marketing, communications, services, and facilities to nurture their growth and success.

Zubi Capital operates as a specialized impact asset and wealth management firm. Guided by the values instilled by their founder and partners, their mission aligns with the belief that investing to achieve both market financial returns and enduring social and environmental impact is not only feasible but also enhances each other's outcomes.

Ship2B Ventures is a venture capital firm that invests in impact startups. As impact investors, they are dedicated to achieving triple profitability—economic, social, and environmental. Integrating principles from both venture capital and impact investing realms, they aim to maximize financial returns while deliberately creating, managing, and measuring the positive impact of their investments.

Cemex Ventures is a corporate venture capital arm of Cemex. They are dedicated to catalyzing the construction revolution through strategic investments and collaborative partnerships with hundreds of startups. Beyond financial support, Cemex Ventures provides startups with direct access to a leading company in the building materials industry. Their commitment extends beyond mere investment; they aim to co-create a path to success tailored to the specific needs of each startup. This approach ensures mutual benefit and supports the development of innovative solutions across all stages of startup growth.

Draper B1 is a seed and early-stage venture capital firm that invests in B2B and B2B2C startups. They are committed long-term investors specializing in seed-stage startups, having supported over 200 founders in the last decade. They maintain a hands-on approach, collaborating closely with entrepreneurs throughout their growth journey. Their focus is on empowering ambitious founders who are dedicated to making significant global impacts.

Invivo Partners, founded by Albert Ferrer and Luis Pareras, is a management company specializing in early-stage investments in the healthcare sector. They leverage a team of highly skilled professionals with expertise in scientific, technical, and financial analysis, supported by a strong network within the health ecosystem. Managed under Invivo Partners, Invivo Ventures operates based on the success of their initial fund, Healthequity, which closed at 60 million euros after registration with CNMV in 2019. Backed by prominent institutions and private investors, Invivo Partners has achieved notable exits and significant funding for their portfolio companies, emphasizing groundbreaking scientific innovations. Their strategic insights into Technology Transfer and ability to identify emerging trends position them as a leading player in Europe's Technology Transfer landscape.

Asabys Partners is a venture capital firm based in Barcelona that invests broadly in human healthcare. The firm is active in the health-tech and biopharma industries, targeting investments in Spain and internationally in highly innovative and transformative technologies. Motivated by the goal of pushing the boundaries of science and medicine, Asabys Partners sources and finances the most disruptive technologies and collaborates with top internal and external talents in the industry. With an entrepreneurial spirit, the firm seeks to be involved in the building and management of its companies, considering itself not just as investors, but as partners and collaborators to its portfolio companies.

BHV Partners is a venture builder specializing in creating healthcare startups by leveraging research and technology from academic and medical institutions. They collaborate closely with scientists to co-found ventures that address medical gaps, providing strategic guidance across technological, corporate, and funding aspects to enhance startup success and longevity. BHV Partners also offers consulting services to technology transfer offices and the biomedical industry. Recognized for their impact, they were named among the top 15 healthcare startups transforming patient care by EU Startup News in 2023.

tQuity specializes in early-stage investments, partnering with founders to provide capital, resources, and expertise for developing Minimum Viable Products (MVPs) and implementing business models. Their team, with extensive experience in startups and innovative projects over the past decade, adds smart capital to drive growth and innovation in new ventures.

Actyus was founded with the mission to invest in Fintech companies across Europe and Latin America, employing value creation strategies and active management. Benefiting from extensive expertise and exclusive access within the Fintech and private equity sectors, Actyus has a distinguished track record, having distributed over €1 billion in alternative products. Their portfolio includes notable companies such as Creditas, MyInvestor, BoomPay, LemonEnergia, Zippi, and Mundi.io, reflecting their commitment to supporting innovative ventures in the financial technology space.